Shanhe Pharmaceutical (300452.SZ) released its semi-annual performance, with a net profit attributable to the parent company of 93.0352 million yuan, a decrease of 2.61% compared to the previous year.

Tencent Finance App News, Shanhe pharmaceutical assistance (300452.SZ) released its interim report for the first half of 2025, with the company's operating income reaching 471 million yuan, a year-on-year increase of 4.65%. The net profit attributable to shareholders of the listed company was 93.0352 million yuan, a year-on-year decrease of 2.61%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 84.754 million yuan, a year-on-year increase of 6.05%. Basic earnings per share were 0.4 yuan.